XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Restructuring and Asset Impairment Charges (Tables)
 3 Months Ended
Jun. 30, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs
Restructuring charges for our fiscal 2019 initiatives during the first quarter of 2020 consisted of the following:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
European Pharmaceutical Solutions
 
Medical-Surgical Solutions
 
Other
 
Corporate
 
Total
Severance and employee-related costs, net
$
(1
)
 
$
(1
)
 
$
—

 
$
—

 
$
6

 
$
4

Exit and other-related costs (1)
—

 
1

 
2

 
1

 
10

 
14

Asset impairments and accelerated depreciation
—

 
3

 
1

 
—

 
1

 
5

Total
$
(1
)
 
$
3

 
$
3

 
$
1

 
$
17

 
$
23

(1)
Exit and other-related costs primarily include project consulting fees.
Restructuring charges for our fiscal 2019 initiatives during the first quarter of 2019 consisted of the following:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
Medical-Surgical Solutions
 
Other
 
Corporate
 
Total
Severance and employee-related costs, net
$
3

 
$
10

 
$
1

 
$
—

 
$
14

Exit and other-related costs (1)
1

 
2

 
21

 
11

 
35

Asset impairments and accelerated depreciation
4

 
—

 
16

 
—

 
20

Total
$
8

 
$
12

 
$
38

 
$
11

 
$
69

(1)
Exit and other-related costs primarily include lease exit costs associated with closures of retail pharmacy stores within our Canadian business as well as project consulting fees.
Schedule of Restructuring and Asset Impairment Charges
The following table summarizes the activity related to the restructuring liabilities associated with our fiscal 2019 initiatives for the first quarter of 2020:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
European Pharmaceutical Solutions
 
Medical-Surgical Solutions
 
Other
 
Corporate
 
Total
Balance, March 31, 2019 (1)
$
31

 
$
38

 
$
15

 
$
29

 
$
37

 
$
150

Restructuring charges recognized
(1
)
 
3

 
3

 
1

 
17

 
23

Non-cash charges
—

 
(3
)
 
(1
)
 
—

 
(1
)
 
(5
)
Cash payments
(1
)
 
(7
)
 
—

 
(12
)
 
(7
)
 
(27
)
Other
—

 
1

 
—

 
(6
)
 
(3
)
 
(8
)
Balance, June 30, 2019 (2)
$
29

 
$
32

 
$
17

 
$
12

 
$
43

 
$
133


(1)
As of March 31, 2019, the total reserve balance was $150 million of which $117 million was recorded in other accrued liabilities and $33 million was recorded in other noncurrent liabilities.
(2)
As of June 30, 2019, the total reserve balance was $133 million of which $107 million was recorded in other accrued liabilities and $26 million was recorded in other noncurrent liabilities.